Biotech Values

[rkrw]

A good ceo should have a long term plan and not just stage events around the interest of short term shareholders who care most about the immediate stock price.

The tactical decision they seem to have made is to retain as much of 534 as they can, in particular, US rights. That takes money.

It seems you want to have both ways with Ariad and the CEO. Raise money now, how awful of him diluting shareholders. Roll the dice on Rida and raise after the data, if it happens to fail, then it will be why didn't he raise money before the data?